15.02.2017 • NewsDede WillamsrenewableGevo

HCS and GEVO in LOI for Offtake Pact

(c) anyaivanova/Shutterstock
(c) anyaivanova/Shutterstock

HCS Group, owner of German hydrocarbons and specialty chemicals manufacturer Haltermann Carless Solutions, has signed a Letter of Intent (LOI) for a long-term definitive offtake agreement with US renewable chemicals and advanced biofuels producer GEVO, based at Englewood, Colorado. The pact would cover the purchase of renewable isooctane in two phases.

The first phase concerns the regular purchase by HCS of renewable isooctane or high octane paraffinic hydrocarbons from GEVO’s demonstration plant located in Silsbee, Texas, USA. The second phase pertains to offtake of renewable isooctane from a commercial plant GEVO intends to build.

Separately, the future partners said they plan to negotiate an offtake agreement for bio-based jet fuel or other products such as bio-based isobutanol.

Securing renewable components is in line with HSC’s commitment to deliver state-of-the-art sustainable solutions to customers, said Henrik Krüpper, chief sustainability officer and member of the executive committee. Patrick Gruber, CEO of GEVO, said the combination of two technical knowhow and new renewable technologies could lead to a “very promising partnership in developing and implementing next-generation biofuels and bio-based chemical products.”

Haltermann Carless has a network of manufacturing facilities in the US, Germany, the UK and France. In addition to its Colorado headquarters and the plant in Texas, GEVO also has production facilities in Luverne, Minnesota, USA.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.